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Abstract
Trypanosoma cruzi elicits reactive oxygen species (ROS) of inflammatory and mitochondrial origin in infected hosts. In this
study, we examined ROS-induced oxidative modifications in the heart and determined whether the resultant oxidized
cardiac proteins are targets of immune response and of pathological significance in Chagas disease. Heart biopsies from
chagasic mice, rats and human patients exhibited, when compared to those from normal controls, a substantial increase in
protein 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), carbonyl, and 3-nitrotyrosine (3-NT) adducts. To evaluate
whether oxidized proteins gain antigenic properties, heart homogenates or isolated cardiomyocytes were oxidized in vitro
and one- or two-dimensional gel electrophoresis (2D-GE)/Western blotting (WB) was performed to investigate the
proteomic oxidative changes and recognition of oxidized proteins by sera antibodies in chagasic rodents (mice, rats) and
human patients. Human cardiomyocytes exhibited LD50 sensitivity to 30 mM 4-HNE and 100 mMH 2O2 at 6 h and 12 h,
respectively. In vitro oxidation with 4-HNE or H2O2 resulted in a substantial increase in 4-HNE- and carbonyl-modified
proteins that correlated with increased recognition of cardiac (cardiomyocytes) proteins by sera antibodies of chagasic
rodents and human patients. 2D-GE/Western blotting followed by MALDI-TOF-MS/MS analysis to identify cardiac proteins
that were oxidized and recognized by human chagasic sera yielded 82 unique proteins. We validated the 2D-GE results by
enzyme-linked immunosorbent assay (ELISA) and WB and demonstrated that oxidation of recombinant titin enhanced its
immunogenicity and recognition by sera antibodies from chagasic hosts (rats and humans). Treatment of infected rats with
phenyl-a-tert-butyl nitrone (PBN, antioxidant) resulted in normalized immune detection of cardiac proteins associated with
control of cardiac pathology and preservation of heart contractile function in chagasic rats. We conclude that ROS-induced,
cardiac-oxidized antigens are targets of immune recognition by antibodies and molecular determinants for pathogenesis
during Chagas disease.
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Introduction
Trypanosoma cruzi is the etiologic agent of Chagas disease.
According to World Health Organization estimates, the overall
prevalence of human T. cruzi infection is at ,16–18 million cases,
and ,120 million people are at risk of infection [1]. Upon
exposure to T. cruzi, hosts elicit strong B and T cell-mediated
immune responses, resulting in control of acute parasitemia
(reviewed in [2,3]). Approximately 30–40% of the infected
individuals, several years after initial exposure, develop clinical
symptoms of irreversible cardiomyopathy, including cardiomegaly,
ventricular dilation and arrhythmia, and heart failure.
Immune-mediated cytotoxic reactions are the source of reactive
oxygen species (ROS, e.g. O2
N2,H 2O2,
NOH) during acute T. cruzi
infection [2,4]. Macrophages and neutrophils present the first line
of defense and contribute to parasite control through respiratory
burst [5,6] supported by activation of NADPH oxidase (NOX) [7],
myeloperoxidase (MPO) [8] and inducible nitric oxide synthase
(iNOS) [9]. In addition, mitochondrial dysfunction of the electron
transport chain resulting in increased leakage of electrons to
molecular oxygen serves as a main source of ROS in the heart
[10]. ROS and secondary by-products of oxidative stress induce
many different types of protein modifications [11]. For example,
ROS react with cysteine-, histidine- and lysine-residues of proteins
to form 4-HNE [12]. In addition, protein-derived aldehydes and
ketones are produced by direct oxidation of arginine, lysine,
proline, or threonine residues [13], and collectively termed protein
carbonyls [12]. ROS modification of membrane polyunsaturated
lipids results in the formation of MDA. Tyrosine residues on
proteins are susceptible to attack by peroxynitrite and result in
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These oxidative modifications of proteins, if not appropriately
prevented, can have cytotoxic effects on the host.
It was recently shown that oxidative stress-induced protein
modifications occur in the myocardium of T. cruzi-infected
experimental animals [15,16,17] and peripheral blood of chagasic
animals [18] and human patients [19,20]. The enhanced
peripheral oxidative stress was associated with non-responsive
glutathione antioxidant defense [19,21] and increased MPO
activity and ROS production in seropositive chagasic patients
[8,19,22]. The extent of myocardial protein oxidation was
pronounced in acute conditions [18] and persisted during the
chronic disease stage. Further, treatment of infected rodents with
an antioxidant (with or without anti-parasite drug) was effective in
controlling the cardiac oxidative pathology [23] and the loss of left
ventricle (LV) function in the chronic stage [24], thus, establishing
the pathological significance of oxidative overload in Chagas
disease.
In this study, we investigated whether oxidative modification of
cardiac proteins occurs in human patients and results in the
formation of new epitopes that, if recognized by B cell-mediated
immune responses, would lead to an immune recognition of the
host and be of pathological importance in cardiac damage during
Chagas disease. We employed an in vitro system of oxidative
modification of human cardiomyocytes or heart homogenates with
oxidants and utilized 2D-GE/Western blotting and mass spec-
trometry approaches to identify the cardiac oxidized proteins that
were targets of antibody responses in chagasic human patients.
Further, we used an experimental model to determine whether the
beneficial effects of treatment with PBN antioxidant in controlling
myocardial oxidative stress and the resultant LV dysfunction [24]
were associated with control of cardiac oxidized antigen formation
and self-directed antibody response in chagasic animals. Our
findings of a number of cardiac proteins that were immunogenic
due to oxidative stress-induced modifications in chagasic patients
and rodents and normalized by PBN treatment in infected rodents
provide clues to the role of cardiac-oxidized antigens in eliciting
self-targeted immune responses during Chagas disease.
Materials and Methods
Animal and parasites
Animal experiments were performed according to the National
Institutes of Health Guide for Care and Use of Experimental
Animals and approved by the University of Texas Medical Branch
Animal Care and Use Committee (ID: 0805029). T. cruzi
trypomastigotes (SylvioX10/4 strain) were propagated in C2C12
cells (ATCC, CRL-1772). C3H/HeN mice (4- to 5-weeks-old,
Harlan Labs) were infected with T. cruzi (10,000 parasites/mouse,
intraperitoneally) and harvested at day 25 and 150 post-infection
(dpi) corresponding to acute and chronic stages of infection and
disease development, respectively. Sprague Dawley rats (4- to 5-
weeks-old, Harlan Labs) were infected with T. cruzi (50,000-
trypomastigotes/rat, intraperitoneally). Rats were given 1.3 mM
PBN (beginning day 0, throughout the course of infection) in
drinking water. The rat plasma samples were obtained at days 40
and 180 post-infection, corresponding, respectively, to acute and
chronic stages of infection and disease development.
Human samples
All procedures for human sample collection were approved by
the institutional review boards at the University of Texas Medical
Branch (ID: 04–257) and the Universidad Nacional de Salta,
Argentina. Written informed consent was obtained from all
individuals before their enrollment in the study. Blood samples
were collected with heparin or without anticoagulant to obtain
plasma and serum, respectively. Trained medical personnel at the
Central Laboratory of San Bernardo Hospital (Salta, Argentina)
conducted blood sampling by venipuncture. Three different
serology tests were used to test sera samples for T. cruzi-specific
antibodies. Those positive by at least two tests were identified as
seropositive. Data included medical history, physical examination
and subjective complaint of frequency and severity of exertional
dyspnea, along with results of electrocardiography (12-leads at rest
and 3-leads with exercise) to reveal cardiac rhythm and
conduction abnormalities, transthoracic echocardiogram to obtain
objective information regarding the left ventricular (LV) contrac-
tile function, and chest X-ray to assess cardiomegaly (cardio-
thoracic ratio .0.5). The severity of exertional dyspnea was
graded according to the New York Heart Association Classifica-
tion (NYHA) [25]. Based on these criteria, seropositive chagasic
patients exhibiting no echocardiography abnormalities, preserved
systolic function (ejection fraction (EF) $55%), no LV dilatations,
but with negligible-to-minor EKG alterations were graded as CD0
or CD1, respectively. Seropositive patients were graded CD2 with
mild-to-moderate systolic dysfunction (EF: 40–54%) and/or LV
dilatation, and CD3 with severe systolic dysfunction (LV end
diastolic diameter $57 mm, EF #40%). Seronegative cardiomy-
opathy patients of other etiologies (OCM) were categorized similar
to the chagasic patients. Normal, seronegative and healthy
individuals exhibiting no history or clinical symptoms of cardiac
disease were used as controls. Cardiac biopsies were obtained from
chagasic patients undergoing correctional surgical intervention for
clinical purposes at the San Bernardo Hospital (Salta, Argentina).
Normal cardiac biopsies were obtained from the National Disease
Research Interchange (NDRI) tissue bank.
Immunohistochemistry
Heart tissue sections were fixed in formalin and embedded in
paraffin. Tissue sections (5-mm) were subjected to immunostaining
for 2 h at room temperature with antibody against 4-HNE (1:500,
Alpha Diagnostics) to visualize aldehydic adducts, and dinitro-
phenylhydrazine (DNPH, 1:200, Sigma) to detect DNP-deriva-
tized carbonyl proteins. Slides were then incubated for 30 min
each with biotinylated IgG (1:200) and streptavidin-conjugated
horseradish peroxidase (HRP, 1:200, Dako), and color was
developed using 3,39 diaminobenzidine substrate (Sigma). Each
tissue section (3 sections/tissue sample) was analyzed for .10-
microscopic fields and scored for adducts as a percentage of total
histological field quantified by using computerized Simple PCI
Software version 6.0 (Compix). In some experiments, slides were
incubated with rhodamine-conjugated secondary antibody, and
fluorescence was visualized on an Olympus BX-15 microscope,
and images captured by using a mounted digital camera.
Cell viability assay
Cardiomyocytes (10
6/ml) were in vitro incubated for 0, 2, 6, 12,
and 24 h with 0–40 mM 4-HNE (Cayman) or 0–200 mMH 2O2
(Sigma). Cells were then incubated with 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT, 5 mg/ml) for 3 h.
The reduction of MTT by mitochondrial dehydrogenases of the
live cells resulted in the formation of purple formazan crystals that
were solubilized in dimethylsulfoxide and absorbance measured at
540 nm by using a spectrophotometer. ROS efficiency was
determined by the lowest concentration of ROS that elicited
50% cell death in minimal time (Percent viability: [mean OD of
samples/mean OD of controls]6100) [26].
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Heart tissue section (tissue: buffer ratio, 1:10 w/v) or cardiomy-
ocytes (10
6 cells/ml) were washed with ice-cold Tris-buffered saline
and homogenized in lysis buffer [15]. Homogenates (1 mg protein/
ml) were in vitro oxidized with 30 mM 4-HNE or 100 mMH 2O2 for
6 h and 12 h, respectively, centrifuged at 3,000 g, 4uC for 10-min
and the resulting supernatant aliquots stored at 280uC.
Two-dimensional gel electrophoresis
The 11-cm immobilized pH gradient (IPG) strips (pH: 3–10,
Bio-Rad) were rehydrated at 50 V for 12 h with 250-ml
rehydration buffer (1 M thiourea, 8 M urea, 2% CHAPS, 1%
dithiothreitol, and 0.2% ampholytes) containing 100-mg protein
samples and 0.002% of bromophenol blue. Isoelectric focusing
was performed at 500 V for 1 h, 1000 V for 1 h, 8000 V for 2 h,
and then at 8000 V for a total of 50,000 V [17]. The IPG strips
were suspended in equilibration buffer (50 mM Tris-HCl, pH 6.8,
6 M urea, 20% glycerol) and sequentially incubated for 15 min
each in the presence of 2% dithiothreitol/2% SDS (reducing
conditions) and 2.5% iodoacetamide/2% SDS (alkylating condi-
tions). Equilibrated IPG strips were subjected to second-dimension
electrophoresis by using 8–10% linear gradient precast Tris-HCl
gels (Bio-Rad) on a PROTEAN plus Dodeca Cell System at 75 V
for 1 h and then at 120 V until the dye front reached the bottom
of the gel. Gels were fixed in 10% methanol/7% acetic acid,
stained with SYPRO Ruby (BioRad), destained in 10% ethanol/
7% acetic acid, and imaged by using a high-resolution
ProXPRESS Proteomic Imaging System (Perkin Elmer).
Protein oxidative modifications
Tissue or cardiomyocyte homogenates (normal and in vitro
oxidized) were resolved by 1-dimension (10 mg protein/well) or 2-
dimension (100 mg protein) gel electrophoresis and proteins
transferred to PVDF membranes by using a wet, vertical Criterion
Blotter (Bio-Rad). Membranes were blocked for 1 h with 5% nonfat
dry milk (NFDM, BioRad) in 50 mM Tris-HCl (pH 7.4) containing
150 mM NaCl and 0.05% Tween-20 (TBST). Membranes were
incubated overnight at 4uC with antibodies against 4-HNE (1:2000,
Alpha Diagnostics), MDA (1:3000, Biodesign), 3-NT (1:2000, Cell
Signaling), or DNP (1:1000, Invitrogen), and washed three times.
All antibody dilutions were made in 5% NFDM-TBST. Mem-
branes were then incubated with appropriate HRP-conjugated
secondary antibody for 1 h, and signal was developed by using an
ECL Plus system (GE-Healthcare). Membranes were stained with
Coomassie blue G250 (Bio-Rad) to confirm an equal loading of
samples. Images were visualized and digitized, and densitometric
analysiswasperformedbyusingaFluorChem8800ImageAnalyzer
System (Alpha Innotech).
For the identification of protein carbonyls by 2D-GE, IPG strips
were loaded with protein samples and subjected to 1
st dimension
isoelectric focusing, as above. IPG strips were then incubated with
1 ml of 3% SDS and 5 mM DNPH/10% trifluoroacetic acid for
25 min. After neutralization with 1.5 ml of 2 M Tris, 30% glycerol,
DNP-derivatizedproteinsamplesinIPGstripsweresubjectedto2
nd
dimension electrophoresis by using 8–10% gradient precast gels
(BioRad), and transferred to PVDF membranes. Membranes were
hybridized with rabbit anti-DNP antibody (1:300, Invitrogen) and
HRP-conjugated goat anti-rabbit secondary antibody (1:1000,
Southern Biotech), and signal detected as above.
Immune recognition of cardiac proteins by chagasic sera
Protein homogenates of cardiomyocytes or heart tissue (normal
and in vitro oxidized) were resolved by 1D- or 2D-GE, and
transferred to PVDF membranes, as above. Membranes were
probed with sera from normal or chagasic rats, mice or human
patients (1:100 dilution) followed by HRP-conjugated secondary
antibody (1:5000, BioRad), and signal was detected by an ECL
plus chemiluminiscence detection system (GE-Healthcare).
Image analysis
2D gels (n=4/group) or Western blots (n=4/group) were
digitalized on a ProXPRESS Proteomic Imaging System (Perkin
Elmer), and the images were analyzed on Progenesis Same-
Spotst
TM software 2.0 (NonLinear Dynamics). Normalized spot
volumes, i.e., the volume of each spot over the volume of all spots
in the gel, were used to compare the different groups, and
candidates were identified as protein spots that changed at least 2-
fold versus their specific control. Statistical significance was
assessed by a two-tailed Student’s t-test and analysis of variance
test (ANOVA) [27], and the p values of ,0.05 were considered
significant for comparison between control and experimental data.
Mass spectrometry and protein identification
Selected spots (1-mm) were excised from the gels and submitted
to trypsin proteolysis as described [17]. In brief, gel spots were
incubated at 37uC for 30 min in 50 mM NH4HCO3, dehydrated
twice for 5 min each in 100-ml acetonitrile and dried, and then, in-
gel proteins were digested at 37uC for 6 h with 10 ml of trypsin
solution (1% trypsin in 25 mM ammonium bicarbonate). After
digestion, 1 ml of peptide mixture was directly spotted onto a
MALDI-TOF-MS/MS target plate with 1 ml of alpha-cyano-4-
hydroxycinnamic acid matrix solution (5 mg/ml in 50% acetoni-
trile). Peptides were analyzed by using a MALDI-TOF/TOF ABI
4800 Proteomics Analyzer (Applied Biosystems). The Applied
Biosystems software package included the 4000 Series Explorer (v.
3.6 RC1) with Oracle Database Schema Version (v. 3.19.0) and
Data Version (3.80.0) to acquire and analyze MS and MS/MS
spectral data. The instrument was operated in a positive ion
reflectron mode with the focus mass set at 1700 Da (mass range:
850–3000 Da). For MS data, 1000–2000 laser shots were acquired
and averaged from each protein spot. Automatic external
calibration was performed by using a peptide mixture with the
reference masses 904.468, 1296.685, 1570.677, and 2465.199.
MALDI MS/MS was performed on several (5–10) abundant ions
from each protein spot. A 1-kV positive ion MS/MS method was
used to acquire data under post-source decay (PSD) conditions.
The instrument precursor selection window was +/2 3 Da.
Automatic external calibration was performed by using reference
fragment masses 175.120, 480.257, 684.347, 1056.475, and
1441.635 (from precursor mass 1570.700).
Applied Biosystems GPS Explorer
TM (v. 3.6) software was used
in conjunction with MASCOT to search the respective protein
database by using both MS and MS/MS spectral data for protein
identification. Protein match probabilities were determined by
using expectation values and/or MASCOT protein scores. The
MS peak filtering included the following parameters: a mass range
of 800 Da to 3000 Da, minimum S/N filter=10, mass exclusion
list tolerance=0.5 Da and mass exclusion list for trypsin and
keratin-containing compounds included masses 842.51, 870.45,
1045.56, 1179.60, 1277.71, 1475.79, and 2211.1. The MS/MS
peak filtering included the following parameters: minimum S/N
filter=10, maximum missed cleavages=1, fixed modification of
carbamidomethyl (C), variable modifications due to oxidation (M),
precursor tolerance=0.2 Da, MS/MS fragment toleran-
ce=0.3 Da, mass=monoisotopic, and peptide charges=+1.
The significance of a protein match, based on the peptide mass
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precursor ions, is presented as expectation values (p,0.001).
Enzyme-linked immunosorbent assay
Human recombinant titin (0.1 mg/ml, Novus Biologicals) was
sonicated three times for 30 sec each at 4uC, and then in vitro
oxidized with 4-HNE (30 mM) or H2O2 (100 mM) for 1 h at 37uC.
A soluble lysate of culture-derived T. cruzi (70% trypomastigotes,
30% amastigotes) was prepared as previously described [28], and
used as a control. Flexible U bottom (96-well) polyvinyl chloride
plates (BD Biosciences) were coated overnight at 4uC with 0.5 mg/
100 ml/well of titin. Plates were blocked for 2 h at 37uC with 200-
ml/well of 1% non-fat dry milk in PBS. After washing with PBS-
0.05% Tween-20 (PBST) and PBS, plates were sequentially
incubated at room temperature for 2 h with test sera (1:100) and
30 min with HRP-labeled isotype-matched IgG (1:5000, BioRad),
and color was developed with 100 ml/well Sure Blue 3,39,5,59-
tetramethylbenzidine substrate (Kirkegaard & Perry Labs). After
stopping the reaction with 2N sulfuric acid, absorbance was
monitored at 450 nm by using a SpectraMax 190 microplate
reader (Molecular Devices).
Data analysis
Data (mean 6 SD) were derived from at least triplicate
observations per sample (.4 samples/group). Normally distribut-
ed data were analyzed by student’s t-test. The level of significance






Oxidative adducts are enhanced in experimental and
human myocardium during Chagas disease
Many different types of protein modifications, e.g., aldehydic
adducts (4-HNE and MDA), carbonyl derivatives, and 3-NT can
be induced by ROS and secondarily by products of oxidative
stress. We performed 1D-GE/WB and immunohistochemistry to
detect oxidative adducts in cardiac biopsies of infected rodents and
human patients (Fig. 1). Densitometry analysis of selected bands
(marked by asterisk) showed 5-fold, 2-fold, 3-fold and 2-fold
increase in the myocardial levels of 4-HNE, MDA, DNP-
derivatized carbonyl, and 3-NT adducts, respectively, in chagasic
rats (Fig. 1A.a–d) and mice (data not shown). The increased level
Figure 1. Oxidative adducts are enhanced in experimental and human myocardium during Chagas disease. (A) Sprague-Dawley rats
(or C3H/HeN mice) were infected with T. cruzi, and cells were harvested at day 40 (acute stage) and 180 (chronic stage) post-infection. Heart
homogenates were resolved on 10% acrylamide gels, and Western blotting was performed with specific antibodies to detect 4 hydroxynonenal (4-
HNE, panel a), malondialdehyde (MDA, panel b), dinitrophenyl (DNP)-derivatized carbonyl (panel c), and 3-nitrotyrosine (3NT, panel d) adducts.
Coomassie blue staining of membranes (panel e) confirmed the equal loading of samples. (B) Cryostat sections of human cardiac biopsies (5-mm) from
normal healthy donors (panels a, c, e) and chagasic patients (panels b, d, f) were submitted to immunohistochemistry as described in Materials and
Methods. Shown are representative images of immunostaining with anti-4-HNE antibodies (panels a, b). Tissue sections were incubated with DNPH to
derivatize carbonyl proteins, and immunostaining was performed with anti-DNP antibody (panels c–f). HRP-conjugated (panels a–d) and rhodamine-
conjugated (panels e, f) secondary antibodies were utilized to capture the color (brown) or fluorescence signal, respectively.
doi:10.1371/journal.pone.0028449.g001
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the acute stage of high parasitemia (Fig. 1A.a–d) and chronic stage
of disease development (data not shown) in infected rodents.
Coomassie blue staining of the membranes confirmed equal
loading of the samples (Fig. 1A.e).
Cardiac tissue biopsies from normal healthy donors and
chagasic human patients were subjected to immunohistochemistry
to detect oxidative adducts (Fig. 1B). Our data showed the
myocardial level of 4-HNE (Fig. 1B.b, score 3) and carbonyl
(Fig. 1B.d & f, score 2 and 3) protein modifications were
significantly increased in chagasic patients in comparison to that
noted in healthy controls (Fig. 1B.a,c,e). In comparison, a marginal
increase in myocardial level of carbonyl and 4-HNE adducts was
observed in cardiomyopathy patients of other etiologies (data not
shown). Together, these data suggested to us that cardiac proteins
are targets of oxidative modifications during infection by T. cruzi
and Chagas disease development in both experimental animals
and human patients.
Oxidative stress-induced changes affected
cardiomyocytes viability
Next, we determined if ROS-induced oxidative modifications
affect cell viability. Cardiomyocytes (mouse and human, 10
6/ml)
were treated in vitro with 4-HNE (0–40 mM) or H2O2 (0–200 mM)
for 0–24 h and an MTT assay was performed to assess cell
viability. Our data showed that human cardiomyocytes were
resistant to 5 mM 4-HNE and 50 mMH 2O2 for at least 12 h and
exhibited only a 12% loss in viability at 24 h (Fig. 2A&B), possibly
indicative of an endogenous antioxidant activity. Human cardio-
myocytes exhibited a linear decline in viability in response to 20–
40 mM 4-HNE (Fig. 2A) and 50–200 mMH 2O2 (Fig. 2B), the slope
of decline in viability being steeper with increasing concentration
of the oxidant. The minimal LD50 value for 4-HNE and H2O2 was
30 mM and 100 mM, resulting in a 50 percent cell death at 6 h and
12 h post-treatment, respectively. Similar results were obtained
when murine cardiomyocytes were treated with 4-HNE or H2O2
(data not shown). These data suggested that oxidative adducts
affect the viability of cardiomyocytes in a dose- and time-
dependent manner. We used cells or tissue lysates (10
6
cardiomyocyte equivalent protein concentration/ml) treated with
30 mM 4-HNE and 100 mMH 2O2 for 6 h and 12 h, respectively,
for all additional studies.
Identification of cardiac proteins susceptible to oxidative
stress
We employed Western blotting in conjunction with 1D-GE and
2D-GE to identify cardiac proteins that are susceptible to oxidative
modifications. We incubated heart homogenates from normal
rodents with 4-HNE or H2O2, and first performed 1D-GE/
immunoblotting with anti-4-HNE (Fig. 3A.a) and anti-DNP
(Fig. 3A.b) antibodies to detect oxidative adducts. Densitometry
analysis of the Western blots showed a 25% and 35% increase in
oxidation level of proteins (marked by asterisk) when cell
homogenates were treated with 4-HNE and H2O2, respectively
(Fig. 3A.e). To facilitate the identification of proteins susceptible to
oxidative stress in humans, 4-HNE- and H2O2-treated cardiomy-
ocyte homogenates were resolved by 2D-GE, and immunoblotting
was performed to detect 4-HNE (Fig. 3B.a–b) and DNP-derivatized
carbonyl (Fig. 3B.c–d) adducts. Gel images were normalized, and
proteins that exhibited at least 2.5-fold increase in oxidative adducts
were identified. These data showed 21 and 19 protein spots were
oxidatively modified in 4-HNE-treated (Fig. 3B.b) and H2O2-
treated (Fig. 3B.d) cardiomyocytes, respectively.
Identification of cardiac proteins recognized by chagasic
immune sera
To determine if oxidation of cardiac proteins increased their
immune recognition by sera antibodies in chagasic host, we
resolved 4-HNE- and H2O2- treated rat heart (Fig. 4A) and
human cardiomyocyte homogenates by 1D-GE and performed
Western blotting with immune sera from chronically infected rats
(Fig. 4A.a) and chagasic human patients (Fig. 4A.c). These data
clearly showed that several cardiac proteins were newly recognized
(marked by asterisk) and other proteins were recognized at a
higher intensity (marked by arrow) by the immune sera from
chagasic rats and humans when the heart homogenates treated
with 4-HNE or H2O2 were used as antigen source as compared to
that noted when normal cardiac homogenates were probed with
chagasic sera. A densitometry analysis of the Western blots showed
a 3-fold and 4-fold increase in antibody recognition of cardiac
Figure 2. Oxidative stress affects cardiomyocyte viability. Human cardiomyocytes were incubated with (A) 4-hydroxynonenal (0–40 mM) or
(B)H 2O2 (0–200 mM) for 0, 2, 6, 12, and 24 h. An MTT assay was performed to examine cell viability (*p,0.05).
doi:10.1371/journal.pone.0028449.g002
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H2O2, respectively, were used as antigen source (Fig. 4A.a), and by
2-fold when human cardiomyocytes treated with 4-HNE or H2O2
were used as an antigen source (Fig. 4A.c). Coomassie staining of
the membranes (Fig. 4A.b&d) confirmed equal loading of the
samples.
Towards discovery of cardiac proteins that became immuno-
genic due to oxidative stress-induced modifications in human
chagasic patients, homogenates of normal cardiomyocytes and
cardiomyocytes in vitro oxidized with 4-HNE or H2O2 were
resolved by 2D-gel electrophoresis, and membranes were probed
with sera from clinically characterized chagasic patients (Fig. 4B).
Protein spots that were differentially recognized (marked on
Fig.S1) were selected for sequencing. The corresponding gels
stained with Sypro Ruby (Fig.S1) were utilized to submit protein
spots recognized by immune sera for MALDI-TOF-MS/MS
analysis and protein identification. In total, we identified 25, 32,
76, and 40 protein spots recognized by sera IgGs from normal
controls (Fig. 4B.a,e,i), chagasic patients characterized as clinically
asymptomatic (CD0–CD1) (Fig. 4B.b,f,j) and symptomatic (CD2–
CD3) (Fig. 4B.c,g,k), and non-chagasic/other cardiomyopathy
(OCM) patients (Fig. 4B.d,h,l). In general, when we probed
normal cardiomyocytes (Fig. 4B.a–d), antibody recognition was
limited to 6, 9, 11, and 8 proteins by sera IgGs from normal
subjects and CD0–CD1, CD2–CD3 and OCM patients, respec-
tively. When we probed 4-HNE-oxidized cardiomyocytes
(Fig. 4B.e–h), we found 21, 22, 42 and 19 protein spots were
recognized by sera IgGs from normal controls and CD0–CD1,
CD2–CD3 and OCM patients, respectively. When we probed
H2O2-oxidized cardiomyocytes (Fig. 4B.i–l), we found 12, 30, 40
and 20 protein spots were recognized by sera IgGs from normal
controls and CD0–CD1, CD2–CD3 and OCM patients, respec-
tively. MALDI-TOF-MS/MS analysis of 82 protein spots that
were uniquely oxidized and recognized by immune sera by $5
fold as compared to normal controls (pANOVA#0.01) yielded 48
unique protein identifications (Table 1). Of note is the immune
recognition by chagasic sera of actin, desmin, and titin that play an
important role in the assembly and function of vertebrate striated
muscles, and vimentin that is a cytoskeletal component responsible
for maintaining cell integrity (Table 1).
Figure 3. Identification of cardiomyocyte proteins susceptible to oxidative stress. (A) Rat heart homogenates were treated in vitro with
30 mM 4-HNE or 100 mMH 2O2, and Western blotting was performed to detect 4-HNE (panel a) and DNP-derivatized carbonyl (panel b) proteins.
Coomassie blue staining of membranes (panels c, d) confirmed the equal loading of samples. Densitometry analysis of oxidized proteins (marked with
asterisk in panels a & b) is shown in panel e (B) Human cardiomyocyte homogenates (1 mg protein/ml) were treated for 6 h with 30 mM 4-HNE or 12 h
with 100 mMH 2O2. Normal (panels a, c, e), 4-HNE-treated (panel b) and H2O2-treated (panels d, f) cell homogenates were subjected to 1
st dimension
isoelectric focusing on 11-cm, linear pH 3–10 immobilized pH gradient (IPG) strips. Strips were incubated with DNPH to derivatize carbonyl proteins,
and 2
nd dimension separation was carried out on 8–10% gradient gels. Membranes were probed with anti-4-HNE (panels a, b) and anti-DNP (panels c,
d) antibodies. Representative images of 2D gels stained with Sypro Ruby are shown (panels e, f). Selected protein spots that were oxidized were
submitted to MALDI-TOF-MS/MS analysis for protein identification (listed in Table 1).
doi:10.1371/journal.pone.0028449.g003
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chagasic patients
To confirm that oxidation-induced changes indeed increased
the immunogenicity of cardiac proteins in chagasic patients, we
utilized human recombinant titin protein (0.1 mg/ml), in vitro
oxidized with 30 mM 4-HNE or 100 mMH 2O2, and performed an
ELISA to identify the serum levels of anti-titin antibodies in
chagasic patients (Fig. 5). We detected moderate levels of anti-titin
antibodies in the sera of chagasic patients compared to that in
normal controls. The antibody recognition of titin by sera
antibodies of chagasic patients was increased by 50–70% when
titin oxidized with 4-HNE or H2O2 was used as an antigen. The
Figure 4. Oxidation of cardiomyocyte proteins enhanced immune recognition by antibodies in chagasic sera. (A) Homogenates of rat
heart (panels a, b) and human cardiomyocytes (panels c, d), in vitro oxidized with 30 mM 4-HNE or 100 mMH 2O2, were resolved by 1D-GE, and Western
blotting was performed with sera from chronically infected rats (panel a) and humans (panel c). Asterisks (panels a, c) indicate the protein bands that
were newly recognized when 4-HNE and H2O2-treated homogenates were probed with chagasic sera from chronically infected rats and humans.
Arrows (panels a, c) indicate the protein bands that were recognized by chagasic sera at a higher intensity when 4-HNE and H2O2-treated
homogenates (instead of normal/untreated homogenate) were used as antigen source, and for which densitometry was performed. Coomassie blue
staining of membranes (panels b, d) confirmed the equal loading of samples. (B) Homogenates of normal cardiomyocytes (panels a–d) and
cardiomyocytes in vitro oxidized with 4-HNE (panels e–h)o rH 2O2 (panels i–l) were resolved by 2D-GE. Western blotting was performed with sera from
normal healthy controls (panels a, e, i), seropositive chagasic patients in the CD0–CD1 (panels b, f, j) or CD2–CD3 phase (panels c, g, k), and
seronegative cardiomyopathy patients of other etiologies (panels d, h, l).
doi:10.1371/journal.pone.0028449.g004
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Spot # Protein name Gene name Accession no Score MW (kDa) E value Sera type
Nor CD0–1 CD2–3
No treatment
1 Prohibitin variant PHB gi|62897923 95 29.8 6.29E-05 + 22
2 Alpha enolase like 1 ENO1 gi|3282243 428 29.8 3.15E-38 2 +++ 2
3 Albumin ALB gi|168988718 200 67.7 1.99E-15 2 +++ 2
4 Desmin DES gi|19908424 594 53.5 1.26E-54 2 + 2
5 Actin beta ACTB gi|14250401 400 41.3 1.99E-35 2 ++ 2
6 Aldehyde dehydrogenase, mt ALDH gi|6137677 544 54.3 7.92E-50 22 +
7 Heat shock 8 isoform 1 HSPA8 gi|5729877 989 71 2.51E-94 22 ++
8 Heat shock protein 1 variant 1, mt HSP1B gi|189502784 473 60.8 9.98E-43 22 +++
9 Thiol antioxidant/Peroxiredoxin 2 PRX2 gi|438069 111 22 1.58E-06 22 +
10 Tubulin beta TUBB gi|57209813 538 48.1 3.15E-49 22 ++
11 Heat shock protein 1, beta HSP1B gi|20149594 392 83.5 1.26E-34 22 2
12 Annexin A3 ANXA3 gi|4826643 85 36.5 6.29E-04 22 2
H2O2-treated
13
# F1ATP synthase complex alpha ATP5A1 gi|127798841 175 59.7 6.29E-13 ++ 22
14 Annexin A2 isoform 1 ANXA2 gi|50845388 108 40.6 3.15E-06 ++ 2 +
15 Lamin A/C, variant 1 LMNA gi|57014045 263 55 9.98E-22 + + +++
16
# Aldolase A ALDA gi|28595 66 11.9 5.00E-02 2 ++ 2
17 Annexin I, chain A ANXA1 gi|157829895 80 35.2 1.99E-03 2 ++ 2
18 Guanine binding protein, beta like GNB2L1 gi|119574080 84 30.9 7.92E-04 22 +++
19 Acute morphine dependence 2 CCT6A gi|14517632 98 58.4 3.15E-05 22 ++
20 Nucleophosmin 1 isoform 3 NPM1 gi|83641870 66 28.4 5.00E-02 2 ++ +
21 Rho GDP dissociation inhibitor a ARHGDIA gi|4757768 84 23.2 7.92E-04 22 ++
22 Annexin A2 isoform 1 ANXA2 gi|50845388 442 40.6 1.26E-39 + 2 +
23 Karyopherin Beta 2 like gi|5107637 77 24.5 3.97E-03 22 +
24
# Enolase 1 ENO1 gi|203282367 111 47.3 1.58E-06 + 22
25 Heat shock protein 5 HSPA5 gi|16507237 234 72.4 9.98E-21 22 2
4-hydroxynonenal (4-HNE)-treated
26 Actin beta ACTB gi|14250401 164 41.3 7.92E-12 22 ++
27 Heat shock protein 8 isoform 1 HSPA8 gi|5729877 524 71 7.92E-48 + 22
28 Prolyl 4-hydroxylase, beta subunit P4HB gi|20070125 491 51.6 1.58E-44 2 ++
29* Vimentin VIM gi|5030431 292 41.6 1.26E-24 2 ++ 2
30* Actin beta ACTB gi|14250401 257 41.3 3.97E-21 22 +
31* Guanine binding protein, beta GNB2L1 gi|119574080 165 30.9 6.29E-12 ++ + +
32 Glutamate dehydrogenase GDH gi|20151189 354 56.3 7.92E-31 2 +++ +
33 Fascin homolog 1 FSCN1 gi|119607750 160 49.1 1.99E-11 + 22
34 Aldehyde dehydrogenase, mt ALDH gi|6137677 326 54.3 5.00E-28 + 22
35 Enolase 1 ENO1 gi|203282367 370 67.7 1.99E-32 2 ++ +
36 Phosphopyruvate hydratase alpha ENO1 gi|693933 236 47.3 6.29E-19 ++ 22
37 Enolase 3 ENO3 gi|153267427 142 47.2 1.26E-09 22 2
38 Heat shock protein 5 HSPA5 gi|16507237 723 72.4 9.98E-68 22 ++
39 Desmin DES gi|55749932 509 53.5 2.51E-46 22 +++
40* Laminin receptor LRP gi|161761214 179 53.6 2.51E-13 22 2
41* Tropomyosin 1 alpha isoform 3 TPM1 gi|63252896 422 32.7 1.26E-37 + 22
42* Albumin ALB gi|168988718 208 67.7 3.15E-16 2 ++ 2
43 Tryptophan 5 monooxygenase YWHAE gi|5803225 79 29.3 2.51E-03 +++ + 2
44 Pyruvate kinase PKM2 gi|31416989 472 58.5 1.26E-42 2 ++ +
45 Ribonucleoprotein A2, B1 isoform RNPA2B1 gi|14043072 397 37.4 3.97E-35 22 +++
46 Annexin A2 ANXA2 gi|56967118 571 36.6 1.58E-52 2 ++ 2
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correlated directly with the disease stage, with a moderate increase
in patients at the CD0/CD1 stage (data not shown), while a
substantial increase was noted in patients at the CD2/CD3 stage
(Fig. 5). In comparison, seronegative patients with cardiac
symptoms due to other etiologies (OCM) exhibited a moderate
level of anti-titin antibodies. The immune recognition of oxidized
titin was not increased in OCM patients (Fig. 5). These data
validated the experimental results presented in Fig. 4 and
suggested to us that the oxidative stress-induced changes in
cardiac antigens enhanced their immunogenicity and recognition
by antibodies elicited in human chagasic patients.
Pathologic significance of immune recognition of
oxidized cardiac antigens in Chagas disease
To corroborate the pathological significance of oxidized cardiac
antigens in Chagas disease, we treated the infected rats with PBN
to control oxidative stress [24]. We collected immune sera of
infected (with and without treatment) rats during the acute and
chronic stages of infection and disease development, and utilized
them to determine the levels of anti-titin antibodies by an ELISA
that used recombinant and oxidized titin as antigens (Fig. 6A). As
expected from the results presented in Fig. 5, our data clearly
demonstrated that an increased detection of recombinant titin by
sera antibodies in infected/untreated chagasic rats was further
enhanced when titin was oxidized with 4-HNE or H2O2.I ti s
important to note that PBN-mediated control of cardiac pathology
and preservation of heart contractile function in chagasic rats [24]
were associated with an up to 50% decline in serum levels of
antibodies to cardiac titin (normal and oxidized forms) in
chronically infected/treated rats (Fig. 6A). Likewise, rat heart
homogenates, in vitro oxidized with 4-HNE or H2O2, as compared
to normal rat homogenate, exhibited 53% and 60%, respectively,
increase in immune recognition by chagasic sera antibodies
(Fig. 6B.b & C). The immune recognition of cardiac proteins
was significantly controlled when rat heart homogenates (normal
and in vitro oxidized with 4-HNE or H2O2) were submitted to
Western blotting with sera samples from infected/PBN-treated
rats, compared to that found with sera samples from infected/
untreated rats (Fig. 6B.c & C). Together, these data demonstrated
that the antigenicity of cardiac proteins is enhanced in an oxidative
stress-dependent manner in chagasic rats. The control of antibody
responses against cardiac proteins (normal and oxidized) in
infected/PBN-treated rats that also exhibited a gain of cardiac
function [24] suggested to us that anti-cardiac antibodies are of
pathologic importance in Chagas disease development.
Discussion
In this study, we examined the pathological significance of
oxidative stress in human chagasic patients. We demonstrated that
myocardial levels of oxidative modifications (4-HNE, carbonyls,
MDA, and 3-NT adducts) were significantly increased in chagasic
patients and experimental animals, and affected cardiomyocytes
viability. By 2D-GE/WB, we found that 48 cardiac proteins
(native or oxidized) exhibited a significant increase in immune
recognition by antibodies in chagasic sera and were identified by
MALDI-TOF-MS/MS analysis. Molecular and functional anal-
ysis allocated a majority of the cardiac proteins recognized by
chagasic sera to the cell death/cell proliferation category and to
molecular pathways associated with hypoxia, mitochondrial
swelling and permeability transition, and hypertrophy and dilation
of the left ventricle. The 2D-GE/WB results were validated by an
ELISA demonstrating recombinant titin, when in vitro oxidized,
was highly immunogenic, and the target of serum antibodies in
chagasic patients and experimental animals. Importantly, treat-
ment of infected rodents with PBN antioxidant resulted in an up to
50% decline in serum levels of antibodies to cardiac-oxidized
proteins, associated with control of cardiac pathology and
Figure 5. Oxidized titin exhibited increased immunogenicity in
chagasic patients. Recombinant titin was in vitro oxidized with 4-HNE
(30 mM) or H2O2 (100 mM). An enzyme-linked immune-sorbent assay
(ELISA) was performed to titer the antibody level against recombinant
and oxidized titin in sera samples of normal healthy controls,
seropositive chagasic patients, and seronegative subjects with cardio-
myopathy of other etiologies (OCM). n=25/group (*p,0.05).
doi:10.1371/journal.pone.0028449.g005
Spot # Protein name Gene name Accession no Score MW (kDa) E value Sera type
Nor CD0–1 CD2–3
47 Vimentin variant 3 VIM gi|167887751 438 53.6 3.15E-39 2 + +++
48* Titin isoform novex-2 TTN gi|110349717 51 3032.8 3.97E-21 2 ++ +
Human cardiomyocyte lysates were treated with 100-mMH 2O2 or 30-mM 4-hydroxynonenal (4-HNE). Cell lysates were resolved by 2 dimensional gel electrophoresis and
probed with sera samples from normal subjects, seropositive chagasic patients that exhibited no clinical disease (CD0–1) or mild-moderate symptoms of clinical disease
(CD2–3), and seronegative other cardiomyopathy (OCM) patients. Protein spots recognized by immune sera were submitted to MALDI-TOF-MS/MS analysis. A 2, +, ++,
and +++ indicates none, mild, moderate and strong recognition of protein spots by immune sera. Gels were also probed with anti-dinitrophenyl (DNP) and anti-4-HNE
antibodies. In column 1, * and
# indicate protein spots that were recognized by anti-HNE and anti-DNP antibodies, respectively.
doi:10.1371/journal.pone.0028449.t001
Table 1. Cont.
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To the best of our knowledge, this is the first study demonstrating
that oxidative stress-induced modifications of cardiac proteins
results in enhanced immune recognition by serum antibodies in
chagasic patients, and this response parallels with the pathologic
events during Chagas disease development.
The etiology of Chagas disease pathogenesis is complex. The
presence of parasite-specific immune responses to T. cruzi parasites
or antigens persistent in the heart has been considered the most
accepted hypothesis to explain inflammatory pathology [29,30]
and resultant myocytolysis in chagasic hearts. Yet, the persistence
and extent of inflammatory processes in chagasic hearts are not in
sync with the low burden of parasites in the chronic stage, thus,
suggesting to us that host responses contribute to the risk of
Chagas disease development. Accordingly, others have attributed
antibody-mediated cytotoxicity [31] and damage caused by tissue-
infiltrating neutrophils [32] to induction of autoimmunity against
cardiac antigens [33,34] in chagasic patients. We and others have
previously shown that oxidative/nitrosative stress is increased
during the course of T. cruzi infection and disease development in
experimental animals and chagasic patients (reviewed in [4]). Our
current studies suggest that exacerbated oxidative stress induced
protein modifications provide epitopes to drive the self-directed
antibody responses in chagasic patients. Other studies have
demonstrated that ROS elicit inflammatory cytokines (e.g.,
TNF-a, IFN-c, IL-1b) in cardiomyocytes infected by T. cruzi
[35,36]. Inflammatory pathology was controlled in chronically
infected experimental animals and human patients by enhancing
the antioxidant status, which was also beneficial in preserving the
cardiac function during Chagas disease [23,24,37,38]. Our recent
observations indicate that the mitochondrial release of ROS due to
electron transport chain dysfunction and enhanced release of
electrons to molecular oxygen is the primary source of oxidative
stress in the heart [10]. These results allow us to propose a unified
Figure 6. Antioxidant treatment arrested the immune recognition of oxidized cardiac antigens in chagasic rats. Sprague Dawley rats
were infected with T. cruzi and treated with phenyl-a-tert-butyl nitrone (PBN, antioxidant) as detailed in Materials and Methods. (A) Recombinant titin
was in vitro oxidized with 4-HNE (30 mM) or H2O2 (100 mM). An ELISA was performed to titer the antibody levels against recombinant and oxidized
titin in sera of normal rats, and rats that were chronically infected and treated with PBN. (B) Rat heart homogenates (normal and in vitro oxidized with
4-HNE or H2O2) were resolved by 1D-GE and Western blotting was performed with sera from normal (panel a), chronically infected (panel b) and
infected/PBN-treated (panel c) rats. Coomassie blue staining of membranes (panel d) confirmed the equal loading of samples. n=6/group (*p,0.05).
(C) Densitometry analysis of protein bands (marked by asterisks in B).
doi:10.1371/journal.pone.0028449.g006
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ROS are initiated by T. cruzi via activation of inflammatory
responses (NADPH oxidase) [39] during the acute stage, and
consistently produced due to mitochondrial dysfunction during the
chronic stage [10]. These ROS, via their ability to modify DNA,
protein and lipids, cause myocytolysis and damage to cardiac
microvasculature. At the same time, oxidized proteins serve as
neoantigens, thereby providing a stimulus for the activation of
innate (neutrophils, macrophages) and antibody response and the
resultant immunocytotoxicity. Our hypothesis is supported by the
observations that treatment with PBN of infected rodents provided
a significant control of cardiac oxidative pathology, cardiac
remodeling, and antibody cytotoxicity directed against cardiac
proteins, and consequently was beneficial in preserving cardiac
hemodynamics and contractile function [23,24].
It is important to note that benefits afforded by PBN treatment
were not linked to diminished persistence of parasites. We have
found similar or higher levels of T. cruzi, determined by real time
PCR approach, in chronically infected/PBN-treated rats as
compared to chronically infected/untreated chagasic rats
[23,24]. This observation provide further support to the idea that
parasite persistence is not sufficient to sustain the chronic evolution
of disease, and host factors (e.g., oxidative stress, oxidized antigens)
play an important role in determining the disease outcome.
Ingenuity Pathway Analysis (IPA) is a highly curated and
comprehensive software used for the integration of proteins into
networks and pathways with biological meaning [40]. Molecular
analysis of the cardiac proteins that were oxidized and/or targets
of antibodies in chagasic sera suggested to us that 19 of the 48
identified proteins (ACTB, ALDOA, ARHGDIA, ATP5A1,
CCT6A, ENO1, GNB2L1, HSP90AB1, HSPA5, HSPA8,
HSPD1, NPM1, P4HB, PHB, PKM2, PRDX2, TPM1, VIM,
YWHAE, p-value: 1.07E-09) play an important role in regulating
cell death and cell proliferation. Following functional analysis, it
was clear that a majority of identified proteins were associated with
a decrease in (ALDOA, ARHGDIA, ATP5A1, CCT6A,
GNB2L1, HSP90AB1, HSPA5, HSPA8, P4HB, PHB, and
YWHAE) or regulation of (ENO1, HSPD1, NPM1, and PRDX2)
cell death [41]. Many of the proteins involved in cell death
regulation (i.e., ATP5A1, GNB2L1, HSPA5, HSPD1, NPM1, and
PRDX2) were also relevant with respect to cell growth and
proliferation [42,43,44]. Other proteins identified in this study
(ANXA2, DES, FSCN1, LMNA, PKM2ENO1 and STAT5B)
have also been characterized to regulate cell growth and
proliferation [42,43,44]. Only a few proteins, i.e., EGCG,
HNRNPA2B1, and TPM1, have been characterized to induce
cell death and/or decrease cell growth in response to various
stimuli [45]. These analyses suggested that cardiomyocytes
proteins that play a role in cell survival and/or cell proliferation
were disproportionately targeted by oxidative stress and antibody
response in chagasic conditions. Indeed, myocardial necrosis [46]
associated with a compromised regeneration of cardiomyocytes
[47] are often observed in clinically symptomatic chagasic
experimental animals and human patients. IPA analysis results
led us to suggest that EGCG, FSCN1, LMNA, PRDX2, and
NPM1 affect, while ANXA2, DES, ENO1, HSPD1, LMNA,
VIM, and MYOD1 regulate differentiation of mouse myoblasts (or
other cell types) in response to various stimuli. We surmise that
oxidative modifications and antigenicity of the cardiac proteins
involved in the regulation of cell survival and cell growth prevent
the preservation of myocardial structure during Chagas disease;
however, this will be verified in future studies.
It also became apparent to us that in addition to their role in
cardiovascular disease, the immunome signature of chagasic
patients (ANXA2, ARHGDIA, FSCN1, GNB2L1, HSP90AB1,
HSPA5, HSPA8, P4HB, PKM2, VIM, YWHAE, p-value: 1.37E-
09) was also indicative of gastrointestinal disorder. Megacolon, by
some estimates, is an under-reported clinical outcome in chagasic
patients [48]. Our studies do not delineate the cellular or tissue
origin of the oxidized proteins, as we have utilized an in vitro model
to test our hypothesis of significance of oxidative stress in eliciting
neo-antigens. Irrespective of the source of oxidized proteins, it can
be deduced that antibodies, once formed, will not be restricted to
the myocardium, and can bind to and alter proteins in multiple
tissues and organs. Indeed, others have reported a predominance
of b1-adrenergic receptor (AR) and muscarinergic 2 (M2) receptor
autoantibodies in Chagas cardiomyopathy patients and of b2-AR
with M2 autoantibodies in megacolon patients, and have
suggested their utility for risk assessment of clinical disease [49].
We surmise that the oxidative stress-induced formation of oxidized
proteins/antigens also has implications in the development of
gastrointestinal disorders in chagasic patients and that organ
selectivity of pathology may be determined by the tissue preference
of the invading parasite strain and resultant cellular source of
target (oxidized) antigens.
In summary, we have provided the first evidence that oxidative
stress-induced protein modifications enhanced a self-directed
antibody response in chagasic experimental animals and human
patients. The oxidation and antigenicity of several of the proteins
that are required for regulating cell death and cell proliferation can
adversely impact myocardial structure during Chagas disease.
Further, we show that the antigenicity of the oxidized self-proteins
may also be of pathological significance in the development of
gastrointestinal disorders in chagasic patients. Our data provide us
with an impetus to investigate the potential utility of ROS
scavengers as adjunct therapy in arresting the progression of
Chagas disease.
Supporting Information
Figure S1 Identification of cardiac protein spots recog-
nized by antibodies in chagasic sera. Homogenates of
normal cardiomyocytes (panels a–d) and cardiomyocytes in vitro
oxidized with 4-HNE (panels e–h)o rH 2O2 (panels i–l) were resolved
by 2D-GE. Western blotting was performed with sera from normal
healthy controls (panels a,e,i), seropositive chagasic patients in
CD0–CD1 phase (panels b,f,j) or CD2–CD3 phase (panels c,g,k), and
seronegative cardiomyopathy patients of other etiologies (panels
d,h,l). Western blots were digitalized on a ProXPRESS Proteomic
Imaging System (Perkin Elmer), and the images were analyzed on
Progenesis SameSpotst
TM software 2.0 (NonLinear Dynamics).
Normalized spot volumes, i.e., the volume of each spot over the
volume of all spots in the gel, were used for comparison of the
different groups, and candidaes were identified as protein spots
that changed at least 5-fold versus their specific control. Candidate
protein spots were cut from the corresponding Sypro Ruby-stained
gels, and submitted for MALDI-TOF-MS/MS analysis for protein
identification (listed in Table 1).
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